CVS is now selling a rival generic version of Mylan’s EpiPen at about a sixth of its price, just months after the maker of the emergency allergy treatment was eviscerated before Congress because of its soaring cost to consumers.
CVS is now selling a rival generic version of Mylan’s EpiPen at about a sixth of its price, just months after the maker of the emergency allergy treatment was eviscerated before Congress because of its soaring cost to consumers. Matt Rourke AP
CVS is now selling a rival generic version of Mylan’s EpiPen at about a sixth of its price, just months after the maker of the emergency allergy treatment was eviscerated before Congress because of its soaring cost to consumers. Matt Rourke AP